1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Covance Sold to LH

Discussion in 'Neogenomics' started by Anonymous, Nov 3, 2014 at 8:48 AM.

  1. Anonymous

    Anonymous Guest

    With Labcrap purchasing Covalence, how long until they pull out of our strategic partnership? What does this mean for NEO?
     
  2. Anonymous

    Anonymous Guest

    The deal with Covance will be unwound quickly. Also, I heard we are getting big cuts on FISH TC up to 60-65% not good